Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

2.70
BATS BZX Real-Time Price
As of 9:48am ET
 -18.90 / -87.50%
Today’s Change
2.60
Today|||52-Week Range
24.00
-81.88%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$95.3M

Company Description

Versartis, Inc. engages in the development of medicines for patients with endocrine disorders. Its clinical candidate, somavartan, a novel, long-acting form of recombinant human growth hormone in late-stage clinical trials for the treatment of growth hormone deficiency in children and adults. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.

Contact Information

Versartis, Inc.
4200 Bohannon Drive
Menlo Park California 94025
P:(650) 963-8580
Investor Relations:
(650) 516-2703

Employees

Shareholders

Individual stakeholders45.60%
Other institutional34.38%
Mutual fund holders30.53%

Top Executives

Jay P. ShepardPresident, Chief Executive Officer & Director
Joshua T. BrummChief Operating & Financial Officer
Robert GutChief Medical Officer, Head-Clinical & Medical
Paul B. WestbergChief Business Officer & Senior Vice President
Shane M. WardSenior Vice President & General Counsel